Enimmune corporation (TPEX:6564)
Taiwan
· Delayed Price · Currency is TWD 17.45
-0.40 (-2.24%)
May 16, 2025, 1:26 PM CST
Enimmune corporation Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 39.92 | 43.49 | 188.42 | 109.82 | 22.88 | Upgrade
|
| Revenue Growth (YoY) | -8.23% | -76.92% | 71.56% | 380.07% | 1076.75% | Upgrade
|
| Cost of Revenue | 25.69 | 66.87 | 167.57 | 71.1 | 14.66 | Upgrade
|
| Gross Profit | 14.23 | -23.37 | 20.84 | 38.72 | 8.22 | Upgrade
|
| Selling, General & Admin | 80.57 | 80.66 | 54.96 | 42.57 | 32.09 | Upgrade
|
| Research & Development | 84.95 | 139.27 | 247.38 | 54.76 | 58.85 | Upgrade
|
| Operating Expenses | 165.37 | 220.1 | 307.26 | 97.39 | 90.94 | Upgrade
|
| Operating Income | -151.14 | -243.48 | -286.42 | -58.67 | -82.72 | Upgrade
|
| Interest Expense | -2.2 | -0.98 | -0.32 | -0.23 | -0.18 | Upgrade
|
| Interest & Investment Income | 2.58 | 1.94 | 1.29 | 2.39 | 1.68 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.6 | -0.34 | 7.45 | 0.01 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -14.21 | 5.16 | 10.9 | 9.25 | 6.77 | Upgrade
|
| Pretax Income | -165.57 | -237.69 | -267.09 | -47.25 | -74.45 | Upgrade
|
| Earnings From Continuing Operations | -165.57 | -237.69 | -267.09 | -47.25 | -74.45 | Upgrade
|
| Minority Interest in Earnings | 8.03 | 13.95 | 19.12 | - | - | Upgrade
|
| Net Income | -157.55 | -223.74 | -247.96 | -47.25 | -74.45 | Upgrade
|
| Net Income to Common | -157.55 | -223.74 | -247.96 | -47.25 | -74.45 | Upgrade
|
| Shares Outstanding (Basic) | 72 | 66 | 64 | 60 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 72 | 66 | 64 | 60 | 53 | Upgrade
|
| Shares Change (YoY) | 8.70% | 3.03% | 6.44% | 12.50% | 21.21% | Upgrade
|
| EPS (Basic) | -2.20 | -3.40 | -3.88 | -0.79 | -1.40 | Upgrade
|
| EPS (Diluted) | -2.20 | -3.40 | -3.88 | -0.79 | -1.40 | Upgrade
|
| Free Cash Flow | -144.25 | -138.13 | -200.98 | -74.53 | -111.61 | Upgrade
|
| Free Cash Flow Per Share | -2.02 | -2.10 | -3.15 | -1.24 | -2.09 | Upgrade
|
| Gross Margin | 35.64% | -53.74% | 11.06% | 35.26% | 35.93% | Upgrade
|
| Operating Margin | -378.66% | -559.79% | -152.01% | -53.42% | -361.61% | Upgrade
|
| Profit Margin | -394.70% | -514.42% | -131.60% | -43.02% | -325.46% | Upgrade
|
| Free Cash Flow Margin | -361.39% | -317.59% | -106.67% | -67.86% | -487.89% | Upgrade
|
| EBITDA | -143.7 | -235.88 | -278.22 | -50.19 | -75.77 | Upgrade
|
| EBITDA Margin | - | - | -147.66% | -45.70% | - | Upgrade
|
| D&A For EBITDA | 7.44 | 7.6 | 8.2 | 8.49 | 6.95 | Upgrade
|
| EBIT | -151.14 | -243.48 | -286.42 | -58.67 | -82.72 | Upgrade
|
| EBIT Margin | - | - | -152.01% | -53.42% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.